Disruptive and Dangerous Agitation

doi:10.1017/9781009181570.003

Chapter 2 - Disruptive and Dangerous Agitation

Published online by Cambridge University Press: 20 July 2023

Edited by

Kaushal Shah and

Mark Curato: Affiliation:
Weill Cornell Medicine, New York
Kaushal Shah: Affiliation:
Weill Cornell Medicine, New York
Christopher Reisig: Affiliation:
Weill Cornell Medicine, New York

Book contents

Get access

Summary

Agitation is a cardinal emergency medicine and prehospital presentation and occurs across a spectrum of severity and risk. Moderately agitated patients can be adequately assessed to exclude dangerous conditions, and if verbal de-escalation fails, may be treated with small doses of a titratable sedative or combination of sedatives, repeated as needed to calm the patient. Dangerously severe agitation is an uncommon medical emergency requiring prompt recognition and treatment in a high-resource care setting. Management focuses on the immediate treatment of agitation so that the patient and others are protected from uncontrolled violence, and so that dangerous causes and effects of agitation are quickly identified and addressed. Once adequate personnel are assembled to safely approach and subdue the patient, face mask oxygen is applied and dangerous restraint holds are relieved. Maximally effective calming medications are administered intramuscularly to quickly treat agitation. As the patient calms, resuscitation-level monitoring and care proceeds, with particular attention to ventilation, as the range of immediately dangerous causes and consequences of agitation are addressed.

Keywords

Agitation Excited Delirium Agitated Delirium Ketamine Restraints Physical Restraints Chemical Restraints Sedation

Type: Chapter
Information: Urban Emergency Medicine , pp. 13 - 25

DOI: https://doi.org/10.1017/9781009181570.003 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Peisah, C, Chan, DK, McKay, R, Kurrle, SE, Reutens, SG. Practical guidelines for the acute emergency sedation of the severely agitated older patient. Internal Med J. 2011;41(9):651–657.Google Scholar

Klein, LR, Driver, BE, Miner, JR, Martel, ML, Hessel, M, Collins, JD, Horton, GB, Fagerstrom, E, Satpathy, R, Cole, JB. Intramuscular midazolam, olanzapine, ziprasidone, or haloperidol for treating acute agitation in the emergency department. Ann Emerg Med. 2018;72(4):374–385.CrossRef Google Scholar PubMed

Wilson, MP, Pepper, D, Currier, GW, Holloman Jr, GH, Feifel, D. The psychopharmacology of agitation: consensus statement of the American Association for Emergency Pyschiatry project beta workshop. West J Emerg Med. 2012;13(1):26–34. PMID: 22461918.Google Scholar

Strayer, R. Jon Cole on Ketamine for Agitation. Emergency Medicine Updates. Available from: https://emupdates.com/jon-cole-on-ketamine-for-agitation (accessed April 23, 2022).Google Scholar

Isbister, GK, Calver, LA, Page, CB, Stokes, B, Bryant, JL, Downes, MA. Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study. Ann Emerg Med. 2010;56(4):392–401.CrossRef Google Scholar PubMed

Knott, JC, Taylor, DM, Castle, DJ. Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department. Ann Emerg Med. 2006;47(1):61–67.CrossRef Google Scholar PubMed

Martel, M, Sterzinger, A, Miner, J, Clinton, J, Biros, M. Management of acute undifferentiated agitation in the emergency department: a randomized double‐blind trial of droperidol, ziprasidone, and midazolam. Acad Emerg Med. 2005;12(12):1167–1172.Google Scholar

Lenzer, J, Solomon, RC. The droperidol dilemma: is the FDA’s black box warning necessary. ACEP News. 2002;3(8).Google Scholar

Hernández-Rodríguez, L, Bellolio, F, Cabrera, D, Mattson, AE, VanMeter, D, Grush, AE, Silva, LJE. Prospective real-time evaluation of the QTc interval variation after low-dose droperidol among emergency department patients. Am J Emerg Med. 2022;52: 212–219.Google Scholar

American College of Emergency Physicians. Policy statements. Ann Emerg Med. 2021;77(6):e127–e133.Google Scholar

Cole, JB, Lee, SC, Martel, ML, Smith, SW, Biros, MH, Miner, JR. The incidence of QT prolongation and torsades des pointes in patients receiving droperidol in an urban emergency department. West J Emerg Med. 2020;21(4):728–736.Google Scholar

Gaw, CM, Cabrera, D, Bellolio, F, Mattson, AE, Lohse, CM, Jeffery, MM. Effectiveness and safety of droperidol in a United States emergency department. Am J Emerg Med. 2020;38(7):1310–1314.Google Scholar

Calver, L, Page, CB, Downes, MA, Chan, B, Kinnear, F, Wheatley, L, Spain, D, Isbister, GK. The safety and effectiveness of droperidol for sedation of acute behavioral disturbance in the emergency department. Ann Emerg Med. 2015;66(3):230–238.Google Scholar

Yap, CY, Taylor, DM, Knott, JC, Taylor, SE, Phillips, GA, Karro, J, Chan, EW, Kong, DC, Castle, DJ. Intravenous midazolam–droperidol combination, droperidol or olanzapine monotherapy for methamphetamine‐related acute agitation: subgroup analysis of a randomized controlled trial. Addiction. 2017;112(7):1262–1269.CrossRef Google Scholar PubMed

Taylor, DM, Yap, CY, Knott, JC, Taylor, SE, Phillips, GA, Karro, J, Chan, EW, Kong, DC, Castle, DJ. Midazolam–droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial. Ann Emerg Med. 2017;69(3):318–326.Google Scholar

Westefer, L, Faust, J. Olanzapine + Benzodiazepines – What Is the FDA Warning About? FOAMcast. Available from: https://foamcast.org/2019/10/29/olanzapine-benzodiazepines-what-is-the-fda-warning-about (accessed April 12, 2022).Google Scholar

Jeffers, T, Darling, B, Edwards, C, Vadiei, N. Efficacy of combination haloperidol, lorazepam, and diphenhydramine vs. combination haloperidol and lorazepam in the treatment of acute agitation: a multicenter retrospective cohort study.J Emerg Med. 2022;62(4):516–523.Google Scholar

Witting, MD, Hsu, S, Granja, CA. The sensitivity of room-air pulse oximetry in the detection of hypercapnia. Am J Emerg Med. 2005;23(4):497–500.Google Scholar

Strömmer, EM, Leith, W, Zeegers, MP, Freeman, MD. The role of restraint in fatal excited delirium: a research synthesis and pooled analysis. Forensic Sci Med Pathol. 2020;16(4):680–692.Google Scholar

Fiscella, K, Pinals, DA, Shields, CG. “Excited delirium,” erroneous concepts, dehumanizing language, false narratives, and threat to Black lives. Acad Emerg Med. 2022;29(7):911–913.Google Scholar

Saadi, A, Naples-Mitchell, J, da Silva Bhatia, B, Heisler, M. End the use of “excited delirium” as a cause of death in police custody. Lancet. 2022;399(10329):1028–1030.Google Scholar

Storey, ML. Explaining the unexplainable: excited delirium syndrome and its impact on the objective reasonableness standard for allegations of excessive force. St Louis Univ Law J. 2012;56(2):10.Google Scholar

Kraines, SH. Bell’s mania. Am J Psychiatry. 1934;91(1):29–40.Google Scholar

ACEP Hyperactive Delirium Task Force. ACEP Task Force Report on Hyperactive Delirium with Severe Agitation in Emergency Settings. American College of Emergency Physicians; 2021. www.acep.org/globalassets/new-pdfs/education/acep-task-force-report-on-hyperactive-delirium-final.pdf (accessed April 28, 2022).Google Scholar

Kupas, DF, Wydro, GC, Tan, DK, Kamin, R, Harrell IV, AJ, Wang, A. Clinical care and restraint of agitated or combative patients by emergency medical services practitioners. Prehosp Emerg Care. 2021;25(5):721–723.Google Scholar

Wong, AH, Ray, JM, Cramer, LD, Brashear, TK, Eixenberger, C, McVaney, C, Haggan, J, Sevilla, M, Costa, DS, Parwani, V, Ulrich, A. Design and implementation of an agitation code response team in the emergency department. Ann Emerg Med. 2022;79(5):453–464.Google Scholar

Stratton, SJ, Rogers, C, Green, K. Sudden death in individuals in hobble restraints during paramedic transport. Ann Emerg Med. 1995;25(5):710–712.Google Scholar

Khawaja, RA, Sikandar, R, Qureshi, R, Jareno, RJ. Routine skin preparation with 70% isopropyl alcohol swab: is it necessary before an injection? Quasi study. J Liaquat Uni Med Health Sci. 2013;12(02):109–114.Google Scholar

Fleming, DR, Jacober, SJ, Vandenberg, MA, Fitzgerald, JT, Grunberger, G. The safety of injecting insulin through clothing. Diabetes Care. 1997;20(3):244–247.Google Scholar

Scheppke, KA, Braghiroli, J, Shalaby, M, Chait, R. Prehospital use of IM ketamine for sedation of violent and agitated patients. West J Emerg Med. 2014;15(7):736–741.Google Scholar

Hopper, AB, Vilke, GM, Castillo, EM, Campillo, A, Davie, T, Wilson, MP. Ketamine use for acute agitation in the emergency department. J Emerg Med. 2015;48(6):712–719.Google Scholar

Green, SM, Andolfatto, G, Krauss, BS. Ketamine and intracranial pressure: no contraindication except hydrocephalus. Ann Emerg Med. 2015;65(1):52–54.Google Scholar

Drayna, PC, Estrada, C, Wang, W, Saville, BR, Arnold, DH. Ketamine sedation is not associated with clinically meaningful elevation of intraocular pressure. Am J Emerg Med. 2012;30(7):1215–1218.Google Scholar

Halstead, SM, Deakyne, SJ, Bajaj, L, Enzenauer, R, Roosevelt, GE. The effect of ketamine on intraocular pressure in pediatric patients during procedural sedation. Acad Emerg Med. 2012;19(10):1145–1150.Google Scholar

Le Cong, M, Humble, I. A ketamine protocol and intubation rates for psychiatric air medical retrieval. Air Med J. 2015 Nov 1;34(6):357–9.Google Scholar

Swaminathan, A. Is Ketamine Contraindicated in Patients with Psychiatric Disorders? RebelEM. Available from: https://rebelem.com/is-ketamine-contraindicated-in-patients-with-psychiatric-disorders (accessed April 23, 2022).Google Scholar

Cole, JB, Moore, JC, Nystrom, PC, Orozco, BS, Stellpflug, SJ, Kornas, RL, Fryza, BJ, Steinberg, LW, O’Brien-Lambert, A, Bache-Wiig, P, Engebretsen, KM. A prospective study of ketamine versus haloperidol for severe prehospital agitation. Clin Toxicol. 2016;54(7):556–562.Google Scholar

Olives, TD, Nystrom, PC, Cole, JB, Dodd, KW, Ho, JD. Intubation of profoundly agitated patients treated with prehospital ketamine. Prehosp Disaster Med. 2016;31(6):593–602.Google Scholar

Lin, J, Figuerado, Y, Montgomery, A, Lee, J, Cannis, M, Norton, VC, Calvo, R, Sikand, H. Efficacy of ketamine for initial control of acute agitation in the emergency department: a randomized study. Am J Emerg Med. 2021;44:306–311.Google Scholar

Mo, H, Campbell, MJ, Fertel, BS, Lam, SW, Wells, EJ, Casserly, E, Meldon, SW. Ketamine safety and use in the emergency department for pain and agitation/delirium: a health system experience. West J Emerg Med. 2020;21(2):272–281.Google Scholar

Barbic, D, Andolfatto, G, Grunau, B, Scheuermeyer, FX, Macewan, B, Qian, H, Wong, H, Barbic, SP, Honer, WG. Rapid agitation control with ketamine in the emergency department: a blinded, randomized controlled trial. Ann Emerg Med. 2021;78(6):788–795.Google Scholar

Riddell, J, Tran, A, Bengiamin, R, Hendey, GW, Armenian, P. Ketamine as a first-line treatment for severely agitated emergency department patients. Am J Emerg Med. 2017;35(7):1000–1004.Google Scholar

Friedman, MS, Saloum, D, Haaland, A, Drapkin, J, Likourezos, A, Strayer, RJ. Description of adverse events in a cohort of dance festival attendees with stimulant-induced severe agitation treated with dissociative-dose ketamine. Prehosp Emerg Care. 2021;25(6):761–767.Google Scholar

Heydari, F, Gholamian, A, Zamani, M, Majidinejad, S. Effect of intramuscular ketamine versus haloperidol on short-term control of severe agitated patients in emergency department; a randomized clinical trial. Bull Emerg Trauma. 2018;6(4):292–299.Google Scholar

Gangathimmaiah, V, Le Cong, M, Wilson, M, Hooper, K, Perry, A, Burman, L, Puckeridge, N, Maguire, BJ. Ketamine sedation for patients with acute behavioral disturbance during aeromedical retrieval: a retrospective chart review. Air Med J. 2017;36(6):311–314.Google Scholar

Parsch, CS, Boonstra, A, Teubner, D, Emmerton, W, McKenny, B, Ellis, DY. Ketamine reduces the need for intubation in patients with acute severe mental illness and agitation requiring transport to definitive care: an observational study. Emerg Med Australas. 2017;29(3):291–296.Google Scholar

Isoardi, KZ, Parker, LE, Page, CB, Humphreys, MA, Harris, K, Rashford, S, Isbister, GK. Ketamine as a rescue treatment for severe acute behavioural disturbance: a prospective prehospital study. Emerg Med Australas. 2021;33(4):610–614.Google Scholar

Bernard, S, Roggenkamp, R, Delorenzo, A, Stephenson, M, Smith, K, Ketamine in Severely Agitated Patients Study Investigators, Augello, M, Buntine, P, Costa, S, Gaeboc, M, Graudins, A. Use of intramuscular ketamine by paramedics in the management of severely agitated patients. Emerg Med Australas. 2021;33(5):875–882.Google Scholar

Isbister, GK, Calver, LA, Downes, MA, Page, CB. Ketamine as rescue treatment for difficult-to-sedate severe acute behavioral disturbance in the emergency department. Ann Emerg Med. 2016;67(5):581–587.Google Scholar

Nash, KA, Tolliver, DG, Taylor, RA, Calhoun, AJ, Auerbach, MA, Venkatesh, AK, Wong, AH. Racial and ethnic disparities in physical restraint use for pediatric patients in the emergency department. JAMA Pediatr. 2021;175(12):1283–1285.Google Scholar

Wong, AH, Taylor, RA, Ray, JM, Bernstein, SL. Physical restraint use in adult patients presenting to a general emergency department. Ann Emerg Med. 2019;73(2):183–192.CrossRef Google Scholar PubMed

Schnitzer, K, Merideth, F, Macias‐Konstantopoulos, W, Hayden, D, Shtasel, D, Bird, S. Disparities in care: the role of race on the utilization of physical restraints in the emergency setting. Acad Emerg Med. 2020;27(10):943–950.Google Scholar

Wong, AH, Whitfill, T, Ohuabunwa, EC, Ray, JM, Dziura, JD, Bernstein, SL, Taylor, RA. Association of race/ethnicity and other demographic characteristics with use of physical restraints in the emergency department. JAMA Network Open. 2021;4(1):e2035241.Google Scholar

Book contents

Chapter 2 - Disruptive and Dangerous Agitation

Summary

Keywords

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive